Exploratory assessment of treatment-dependent random-effects distribution using gradient functions

[1] A Agresti, B Caffo, and P Ohman-Strickland. 2004. Examples in which misspecifcation of a random effects distribution reduces effciency, and possible remedies. Comput Stat Data Anal. 47 (2004), 639–653.

[2] P Albert. 2012. A linear mixed model for predicting a binary event from longitudinal data under random effects misspecification. Stat Med. 31 (2012), 143–154.

[3] T Baghfalakia, M Ganjalib, and G Verbeke. 2017. A shared parameter model of longitudinal measurements and survival time with heterogeneous random-effects distribution. J Appl Stat. 44, 15 (2017), 2813–2836.

[4] K Cheon, P Albert, and Z Zhang. 2012. The impact of random-effect misspecification on percentile estimation for longitudinal growth data. Stat Med. 31 (2012), 3708–3718.

[5] M Daniels and Y Zhao. 2003. Modelling the random effects covariance matrix in longitudinal data. Stat Med. 22, 10 (2003), 1631–1647.

[6] M De Backer, P De Keyser, C De Vroey, and E Lesaffre. 1996. A 12-week treatment for dermatophyte toe onychomycosis terbinafine 250mg/day vs. itraconazole 200mg/day-a double-blind comparative trial. Br J Dermatol. 134, 46 (1996), 16–17.

[7] M Gosho and K Maruo. 2018. Effect of heteroscedasticity between treatment groups onmixed-effects models for repeated measures. Pharm Stat. 17 (2018), 578–592.

[8] P Heagerty. 1999. Marginally specified logistic-normal models for longitudinal binary data. Biometrics. 55 (1999), 688–698.

[9] P Heagerty and B Kurland. 2001. Misspecified maximum likelihood estimates and generalised linear mixed models. Biometrika. 88, 4 (2001), 973–985.

[10] P Heagerty and S Zeger. 2000. Marginalized multilevel models and likelihood inference. Stat Sci. 15, 1 (2000), 1–26.

[11] M Hoque and M Torabi. 2018. Modeling the random effects covariance matrix for longitudinal data with covariates measurement error. Stat Med. 37 (2018), 4167–4184.

[12] K Lee, J Lee, J Hagan, and J Yoo. 2012. Modeling the random effects covariance matrix for generalized linear mixed models. Comput Stat Data Anal. 55, 6 (2012), 1545–1551.

[13] S Litiere, A Alonso, and G Molenberghs. 2007. Type I and type II error under random-effects misspecification in generalized linear mixed models. Biometrics. 63 (2007), 1038–1044.

[14] S Litiere, A Alonso, and G Molenberghs. 2008. The impact of a misspecified random-effects distribution on the estimation and the performance of inferential procedures in generalized linear mixed models. Stat Med. 27 (2008), 3125–3144.

[15] L Liu and Z Yu. 2008. A likelihood reformulation method in non-normal random effects models. Stat Med. 27 (2008), 3105–3124.

[16] L Marquart and M Haynes. 2018. Misspecification of multimodal random-effect distributions in logistic mixed models for panel survey data. J R Stat Soc Ser A Stat Soc. 182, 1 (2018), 305–321.

[17] J Neuhaus, W Hauck, and J Kalbfleisch. 1992. The effects of mixture distribution misspecification when fitting mixed-effects logistic models. Biometrika. 79, 4 (1992), 755–762.

[18] JM Neuhaus and CE McCulloch. 2006. Separating between- and within-cluster covariate effects by using conditional and partitioning methods. J R Stat Soc Series B Stat Methodol. 68, 5 (2006), 859–872.

[19] Y Ouchi, J Sasaki, H Arai, K Yokote, K Harada, Y Katayama, T Urabe, Y Uchida, M Hayashi, N Yokota, H Nishida, T Otonari, T Arai, I Sakuma, K Sakabe, M Yamamoto, T Kobayashi, S Oikawa, S Yamashita, H Rakugi, T Imai, S Tanaka, Y Ohashi, and M Hideki Ito Kuwabara. 2019. Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75). Circulation. 140 (2019), 992–1003.

[20] G Verbeke and E Lesaffre. 1996. A linear mixed-effects model with heterogeneity in the random-effects population. J Am Stat Assoc. 91, 433 (1996), 217–221.

[21] G Verbeke and E Lesaffre. 1997. The effect of misspecifying the random-effects distribution in linear mixed models for longitudinal data. Comput Stat Data Anal. 23 (1997), 541–556.

[22] G Verbeke and G Molenberghs. 2013. The gradient function as an exploratory goodness-of-fit assessment of the random-effects distribution in mixed models. Biostatistics. 14, 3 (2013), 477–490.